GlassScriptPhysician profile
Allison M Casper
NPI 1740502996
$1,733.73
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $841 · 2022: $612 · 2024: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.28 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $125.82 | 2021-2024 | Enhertu |
| Astellas Pharma US INC | $109.66 | 2021-2024 | Vyloy |
| Novartis Pharmaceuticals Corporation | $104.70 | 2021-2022 | |
| Abbvie INC. | $73.13 | 2022-2024 | |
| Blueprint Medicines Corporation | $70.56 | 2021-2022 | |
| Lilly USA, LLC | $69.11 | 2021-2022 | |
| Seagen INC. | $62.25 | 2021-2022 | |
| Incyte Corporation | $58.99 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $57.76 | 2022 | |
| Eisai INC. | $56.95 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.37 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $54.21 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.29 | 2021-2022 | |
| Amgen INC. | $46.91 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $45.75 | 2021-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Casper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.